Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Compounding Pharmacies Market

Compounding Pharmacies Market Size

  • Report ID: GMI749
  • Published Date: Jun 2024
  • Report Format: PDF

Compounding Pharmacies Market Size

Compounding Pharmacies Market size was valued at USD 12.4 billion in 2023 and is anticipated to witness growth at a CAGR of 5.6% between 2024 and 2032. One major driver is the increasing demand for personalized medications, which cater to specific patient needs that are unmet by commercially available drugs. This trend is particularly notable in the treatment of chronic diseases, pediatric, geriatric, and veterinary medicine, where customized dosages and formulations are crucial.

 

Additionally, advancements in pharmaceutical compounding technologies and practices have enhanced the safety, efficacy, and accessibility of compounded medications. Regulatory support and guidelines promoting safe compounding practices also contribute to market growth. Furthermore, the shortage of certain medications and drug recalls have underscored the importance of compounding pharmacies in ensuring continuous patient care. Rising healthcare costs and the shift towards cost-effective treatment options further boost the demand for compounded drugs.
 

Compounding pharmacies are specialized pharmacies that create customized medications tailored to the specific needs of individual patients. Unlike standard pharmacies that dispense mass-produced drugs, compounding pharmacies mix ingredients to formulate medications that are not commercially available or to alter existing medications to meet unique patient requirements. This can include adjusting dosage strengths, flavoring medications for palatability, excluding non-essential ingredients that cause allergies, or providing alternative forms of medications such as creams, gels, or liquids for patients who have difficulty swallowing pills.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Compounding pharmacies market was valued at USD 12.4 billion in 2023 and is anticipated to witness growth at 5.6% CAGR through 2032 driven by the increasing demand for personalized medications.

The pain management segment in the market held 33.3% share in 2023 owing to growing incidence of chronic pain among adults and rising geriatric population.

North America compounding pharmacies market was valued at USD 6.8 billion in 2023 and is anticipated to reach USD 11 billion by 2032 as participants are focusing on the development of compounded medications to better manage patients.

B. Braun Melsungen AG, Clinigen Group PLC, Dougherty's Pharmacy, Inc., Fagron NV, Fresenius Kabi AG, ITC Compounding Pharmacy, Institutional Pharmacy Solutions, LLC, Lorraine’s Pharmacy, McGuff Compounding Pharmacy Services, and Nephron Pharmaceuticals Corporation, among others.

Compounding Pharmacies Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 771
  • Countries covered: 28
  • Pages: 252
 Download Free Sample